Delivery Order SPE2DB22D2103-SPE2DB24FR9YV
Award Date
9/17/24
Potential Completion Date
9/18/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tobramycin 300 mg/5 ml ampules, a medication used for various medical conditions. The contract has a ceiling value of $1,148.11 and a period of performance running through February 27, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,434.99 firm fixed-price delivery order is for the supply of Tobramycin 300 mg/4 ml ampules, a critical antibiotic medication. The contract has an ultimate completion date of May 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $4,119.26 firm fixed price contract is for the supply of 4,558,749,565 units of the drug Tobramycin 300 mg/5 ml ampules. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the provision of Tobramycin 300 mg/5 ml ampules, a specialty pharmaceutical product, with a total potential value of $2,037.22. The contract has a period of performance through January 26, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,513.70 Firm Fixed Price delivery order is for the supply of 4,566,264,597 units of Tobramycin 300 mg/4 ml Ampules. The award has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order issued under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order is for 4,565,218 units of Tobramycin 300 mg/5 ml ampules, a specialty medication, at a firm fixed price of $1,258.06. The contract has a period of performance through July 23, 2024 and does not have any set-aside designation, indicating open competition....
This is a $4,134.34 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tobramycin 300 mg/5 ml ampule in 5 ml units. The order has an ultimate completion date of April 8, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $28,502.07 to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The order is for the supply of 4,564,261,702 units of the medication Tobramycin 300 mg/4 ml ampules. The delivery order has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp, as a prime contractor, also holds an indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00 through...
This federal contract award, valued at $2,997.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tobramycin 300 mg/5 ml ampules, with a completion date of December 2, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The delivery order, valued at $1,157.19, is for the provision of Tobramycin Pak 300 mg/5 ml, a pharmaceutical product. The delivery order has a firm fixed price structure and a completion date of January 29, 2024. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp, as the prime...